Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers | 2020 | September
Share:
About
Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort.
MDS Podcast
Science
Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort.